Central Venous Pressure Monitoring and Prognosis of High-risk Operating Patients
NCT ID: NCT04596332
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
196 participants
OBSERVATIONAL
2014-02-01
2020-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spectral Analysis of Central Venous Pressure Waveform
NCT04733547
Pontos-Central Venous Pressure and Cardiac Surgery
NCT03423420
Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation
NCT04935814
Ultrasound of the Inferior Vena Cava in the Prevention of Hypotension After Induction of General Anesthesia
NCT06530901
Mean Systemic Pressure Measurement During Prone Position Surgery
NCT01957605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Central venous pressure is a localized parameter of the superior vena cava or the right atrium and is closely related to the right ventricular end-diastolic pressure. With volume overload, CVP levels may be abnormally elevated. Maintaining central venous pressure as low as possible is conducive to the recovery of internal organs during haemodynamic treatment, especially for the kidney, intestine, and brain, etc. However, elevated central venous pressure (CVP) occurs frequently in critical care settings, including postoperative critical patients. In this study, we conducted a retrospective study of the relationship between the initial levels of CVP with organ dysfunction, the severity of illness, the length of ICU stay, and prognosis of critically ill patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Patients with the initial central venous pressure(CVP1) \<8 mm Hg
no intervention measures
Because this study was a retrospective study, no intervention measures were implemented for the patients enrolled.
Group B
Patients with 8≤CVP1≤12mm Hg
no intervention measures
Because this study was a retrospective study, no intervention measures were implemented for the patients enrolled.
Group C
Patients with CVP1\>12 mm Hg
no intervention measures
Because this study was a retrospective study, no intervention measures were implemented for the patients enrolled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention measures
Because this study was a retrospective study, no intervention measures were implemented for the patients enrolled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fujian Provincial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiuling Shang
Department of Critical Care Medicine, Fujian Provincial Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jiafang Wu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Critical Care Medicine, Fujian Provincial Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K2018-09-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.